Table 1 Demographics and selected blood laboratory data in BBS patients

Gender M

49.0% (n = 24)

48.1% (n = 13)

50.0% (n = 11)

F

51.0% (n = 25)

51.9% (n = 14)

50.0% (n = 11)

Age (years)

17.8 ± 11.4 (16.8; 1.1–51)

9.7 ± 5.1 (10.8; 1.1–17.6)

27.6 ± 9.0 (24.5; 18–51)

Height (cm)

151.7 ± 26.6 (161; 81–191)

138.2 ± 28.3 (148; 81–178.9)

168.4 ± 9.2 (169.5; 150.6–191)

Weight (kg)

77.8 ± 35.8 (85; 16.0–139.7)

62.8 ± 35.8 (62.5; 16.0–139.7)

96.2 ± 25.8 (93.8; 44.7–139.7)

BMI (kg/m²)

31.5 ± 9.2 (30.8, 18.6–55.2)

29.5 ± 8.9 (26.0, 18.9–55.2)

33.9 ± 9.0 (31.6, 18.6–50.7)

Height SDS

0.02 ± 1.29 (-0,05; -3.01–3.04)

0.25 ± 1.38 (0.16; -3.01–3.04)

-0.23 ± 1.13 (-0,26; -2.20–2.00)

Weight SDS

2.13 ± 1.33 (2.34; -2.09–4.91)

2.62 ± 1.18 (2.79; 0.50–4.91)

1.57 ± 1.24 (1.84; -2.09–2.90)

BMI SDS

2.64 ± 1.18 (2.62; -1.22–4.71)

2.77 ± 0.91 (2.85; 0.75–4.43)

2.50 ± 1.45 (2.35; -1.22–4.71)

GFR reduced

27% (13/49)

26% (7/27)

27% (6/27)

Kreatinin (umol/l)

92 ± 89 (66; 25–494)

67 ± 42 (57; 25–249)

127 ± 120 (80; 56–494)

GOT/AST (U/l)

38 ± 31 (28; 16–210)

45 ± 38 (41; 16–210)

28 ± 12 (25; 16–68)

GPT/ALT (U/l)

41 ± 35 (29; 9–195)

43 ± 37 (33; 15–195)

37 ± 30 (26; 9–139)

GGT (U/l)

47 ± 73 (20; 8–325)

48 ± 83 (19; 8–325)

46 ± 59 (22; 12–240)

AP (U/l)

186 ± 115 (144; 25–427)

250 ± 106 (255; 25–427)

98 ± 50 (94; 27–222)